Making a difference
17 November 2014
Anna is making a difference every day to the lives of her patients. With your support, you can make a difference too.
When Melanoma Institute Australia (MIA) patients at the Poche Centre are first diagnosed with advanced melanoma Anna Hoadley is there.
She is our Clinical Nurse Consultant, and serves as a link between patients and their doctor. Anna is someone they can call with questions and to help co-ordinate their care during what is often the most emotionally tumultuous and stressful time of their lives.
When not in the clinic Anna is on the phone to patients talking about treatment options, dealing with side-effects, co-ordinating tests and scans, speaking to family members, organising referrals, triaging new patient referrals, and much more!
“Having someone to co-ordinate care and understand medically what is going on, to understand their treatments and help improve their quality of life, is so important to our patients,” says Anna.
“Without a Clinical Nurse Consultant, there would be a lot more emotional and physical struggle for our patients.”
One of the hundreds of patients that Anna looks after each year is Trish Nugent. Trish has stage 4 melanoma and has benefitted greatly from Anna’s care.
“Knowing that somebody is helping in such a significant way, to keep me around so that I can be with my family for longer, makes me so very grateful,” Trish says.
“Anna is my inspiration and a joy to see every three weeks, even in the low times. She keeps me fighting.”
With more funding we can expand this program to fund Clinical Nurse Consultants at our other affiliate locations and ensure every patient receives this same exceptional level of care
Your donation today will make a tangible difference to the lives of people, like Trish, and make their struggle that much easier by providing a helping hand in their time of need.
The ESMO conference provided a platform for announcing a number of key melanoma research findings - including practice-changing research from MIA.
Australian researchers have successfully trialled a combination of new treatments to prevent melanoma from spreading to distant organs.
A new treatment that combines an antibody with a cancer-killing virus improves outcomes for patients with advanced melanoma, an international clinical trial has shown.
It feels like groundhog day - another reality TV show, another batch of blatantly sunburnt contestants.
Wouldn’t it be great if your doctor could know if you would respond to treatment before you even had it?
In our latest research update we showcase research in survival estimates, uncover biomarkers, and reveal practice-changing research in surgery and medical oncology.
Senior Clinical Trial Coordinators, like Sarah Lane, support melanoma patients throughout the clinical trial process.
Melanomas are often hard to differentiate from moles. But new technology is helping to improve accuracy of diagnosis.
We are excited to announce that SunSense will proudly be an official supporter of Melanoma Institute Australia. SunSense is an Australian, family owned business.
Five years ago Julie Randall was diagnosed with melanoma and was given months to live. The melanoma had spread throughout her body. The doctors said it was incurable and she’d be lucky if she survived the next nine months. Julie, a patient at Melanoma Institute Australia under Professor Georgina Long was placed on an experimental drug trial. To watch the entire program, visit 9now.com or click here.
Meet our latest Surgical Oncology Fellow, Eva Nagy, to find out more about life as a surgical oncologist, why she came to MIA and what she hopes to achieve.
Melanoma research at ASCO this year focussed on the more precise use of current treatments to ensure optimal treatment for each patient.
MIA recently demonstrated that reflectance confocal microscopy is a useful tool in the clinic to diagnose suspicious-looking lesions in the mouth.
New research is likely to change the way melanoma is managed in many patients by reducing the need for major surgery and its associated morbidity and cost.
Researchers from MIA will present their latest research findings to the world’s largest oncology conference in early June.
Australian researchers pioneer life-extending treatment for advanced melanoma patients with brain tumours
Australian researchers are the first to demonstrate that patients with advanced melanoma which has spread to the brain can have increased life expectancy and possibly even beat the disease.
Melanoma March 2017 - that's a wrap! Thank you to everyone that helped make it happen.
Thank you so much to all those who contributed in a variety of ways to Melanoma March 2017 in 17 different locations and more around the country! You have contributed to getting the Big Data for Melanoma national Research Project happening!
By looking at the ‘dark matter’ of the genome, new research has found that genetic changes in acral and mucosal melanoma are completely different to mutations found in skin melanoma.